Marimed (MRMD) Cash & Current Investments (2011 - 2026)
Marimed (MRMD) posted quarterly Cash & Current Investments of $7.9 million for Q1 2026, up 10.22% year-over-year from $7.2 million in Q1 2025, and down 10.66% quarter-over-quarter from $8.9 million in Q4 2025.
Marimed (MRMD) Cash & Current Investments (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Cash & Current Investments for 16 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 10.22% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (up 10.22% YoY), while the FY2025 annual figure was $8.9 million, up 22.0% from the prior year.
- Cash & Current Investments retreated to $7.9 million in Q1 2026 per MRMD's latest filing, from $8.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $34.7 million in Q1 2022 and bottomed at $6.1 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $12.2 million across 5 years, with a median of $9.9 million in 2022.
- On a YoY basis, Cash & Current Investments climbed as much as 154.72% in 2022 and fell as far as 67.06% in 2022.
- Marimed's Cash & Current Investments stood at $9.9 million in 2022, then jumped by 49.42% to $14.7 million in 2023, then slumped by 50.57% to $7.3 million in 2024, then rose by 22.0% to $8.9 million in 2025, then declined by 10.66% to $7.9 million in 2026.
- Business Quant data shows MRMD's Cash & Current Investments at $7.9 million in Q1 2026, $8.9 million in Q4 2025, and $6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 8.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.44 Mn |
| Mar 31, 2026 | 7.94 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 7.28 Mn |
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 10.19 Mn |
| Mar 31, 2024 | 15.23 Mn |
| Dec 31, 2023 | 14.73 Mn |
| Sep 30, 2023 | 13.42 Mn |
| Jun 30, 2023 | 14.74 Mn |
| Mar 31, 2023 | 21.70 Mn |
| Dec 31, 2022 | 9.86 Mn |
| Sep 30, 2022 | 11.39 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | 34.72 Mn |
| Dec 31, 2021 | 29.93 Mn |
| Sep 30, 2021 | 25.58 Mn |